questionText: To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential impact of the (a) methods and (b) processes used by the National Institute for Health and Care Excellence on access to medicines for patient
answerText: The National Institute for Health and Care Excellence (NICE) can recommend most rare disease medicines that it appraises through the technology appraisal programme for some or all eligible patients. NICE has no current plans to undertake a modular update ...
heading: Rare Diseases: Drugs